Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 42,30
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
EUR 47,63
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 520 pages. 10.50x8.25x1.00 inches. In Stock.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 58,89
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 64,46
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Partridge Publishing Singapore, 2023
ISBN 10: 1543772676 ISBN 13: 9781543772678
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 72,81
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 77,02
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 2014 edition. 135 pages. 9.00x6.00x0.25 inches. In Stock.
Anbieter: moluna, Greven, Deutschland
EUR 48,37
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 87,48
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
EUR 88,81
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 366 pages. 9.25x6.00x0.83 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 88,81
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 336 pages. 9.25x6.00x0.76 inches. In Stock.
EUR 89,61
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 382 pages. 9.00x6.10x0.87 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 89,61
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 412 pages. 9.30x6.15x0.93 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 90,65
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 512 pages. 9.25x6.25x1.16 inches. In Stock.
Anbieter: Phatpocket Limited, Waltham Abbey, HERTS, Vereinigtes Königreich
EUR 106,18
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Used - Good. Volume 3 only. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre.' Ex-library, but has been well cared for. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Anbieter: NEPO UG, Rüsselsheim am Main, Deutschland
Gebundene Ausgabe. Zustand: Gut. 365 Seiten ex Library Book aus einer wissenschaftlichen Bibliothek Sprache: Englisch Gewicht in Gramm: 550.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 123,28
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 154,05
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 156 pages. 9.25x6.50x0.75 inches. In Stock.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 197,02
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 326 pages. 9.25x6.10x9.21 inches. In Stock.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 225,65
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 225,65
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Enzyme- and Transporter-Based Drug-Drug Interactions | Progress and Future Challenges | K. Sandy Pang (u. a.) | Taschenbuch | xviii | Englisch | 2014 | Springer | EAN 9781489994899 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Sprache: Englisch
Verlag: Springer New York, Copernicus, 2010
ISBN 10: 1441908390 ISBN 13: 9781441908391
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Germination of the thought of 'Enzymatic- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges' Proceedings came about as part of the annual meeting of The American Association of Pharmaceutical Scientists (AAPS) that was held in San Diego in November of 2007. The attendance of workshop by more than 250 pharmaceutical scientists reflected the increased interest in the area of drug-drug interactions (DDIs), the greater focus of PhRMA, academia, and regulatory agencies, and the rapid pace of growth in knowledge. One of the aims of the workshop was to address the progress made in quantitatively predicting enzyme- and transporter-based DDIs as well as highlighted areas where such predictions are poor or areas that remain challenging for the future. Because of the serious clinical implications, initiatives have arisen from the FDA (fda.gov/cber/gdlns/interactstud.htm) to highlight the importance of enzyme- and transporter-based DDIs. During the past ten to fifteen years, we have come to realize that transporters, in addition to enzymes, play a vital role in drug elimination. Such insight has been possible because of the continued growth in PK-ADME (pharmacokinetics-absorption-distribution-metabolism-excretion) knowledge, fueled by further advances in molecular biology, greater availability of human tissues, and the development of additional and sophisticated model systems and sensitive assay methods for studying drug metabolism and transport in vitro and in vivo. This has sparked an in-depth probing into mechanisms surrounding DDIs, resulting from ligand-induced changes in nuclear receptors, as well as alterations in transporter and enzyme expression and function. Despite such advances, the in vitro and in vivo study of drug interactions and the integration of various data sets remain challenging. Therefore, it has become apparent that a proceeding that serves to encapsulate current strategies, approaches, methods and applications is necessary. As Editors, we have assembled a number of opinion leaders and asked them to contribute chapters surrounding these issues. Many of these are the original Workshop speakers whereas others had been selected specially to contribute on topics related to basic and applied information that had not been covered in other reference texts on DDI. The resulting tome, entitled Enzyme- and Transporter-Based Drug Interactions: Progress and Future Challenges, comprises of four sections. Twenty-eight chapters covering various topics and perspectives related to the subject of metabolic and transporter-based drug-drug interactions are presented.
Sprache: Englisch
Verlag: Springer New York, Springer New York, 2014
ISBN 10: 1489994890 ISBN 13: 9781489994899
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Germination of the thought of 'Enzymatic- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges' Proceedings came about as part of the annual meeting of The American Association of Pharmaceutical Scientists (AAPS) that was held in San Diego in November of 2007. The attendance of workshop by more than 250 pharmaceutical scientists reflected the increased interest in the area of drug-drug interactions (DDIs), the greater focus of PhRMA, academia, and regulatory agencies, and the rapid pace of growth in knowledge. One of the aims of the workshop was to address the progress made in quantitatively predicting enzyme- and transporter-based DDIs as well as highlighted areas where such predictions are poor or areas that remain challenging for the future. Because of the serious clinical implications, initiatives have arisen from the FDA (fda.gov/cber/gdlns/interactstud.htm) to highlight the importance of enzyme- and transporter-based DDIs. During the past ten to fifteen years, we have come to realize that transporters, in addition to enzymes, play a vital role in drug elimination. Such insight has been possible because of the continued growth in PK-ADME (pharmacokinetics-absorption-distribution-metabolism-excretion) knowledge, fueled by further advances in molecular biology, greater availability of human tissues, and the development of additional and sophisticated model systems and sensitive assay methods for studying drug metabolism and transport in vitro and in vivo. This has sparked an in-depth probing into mechanisms surrounding DDIs, resulting from ligand-induced changes in nuclear receptors, as well as alterations in transporter and enzyme expression and function. Despite such advances, the in vitro and in vivo study of drug interactions and the integration of various data sets remain challenging. Therefore, it has become apparent that a proceeding that serves to encapsulate current strategies, approaches, methods and applications is necessary. As Editors, we have assembled a number of opinion leaders and asked them to contribute chapters surrounding these issues. Many of these are the original Workshop speakers whereas others had been selected specially to contribute on topics related to basic and applied information that had not been covered in other reference texts on DDI. The resulting tome, entitled Enzyme- and Transporter-Based Drug Interactions: Progress and Future Challenges, comprises of four sections. Twenty-eight chapters covering various topics and perspectives related to the subject of metabolic and transporter-based drug-drug interactions are presented.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 311,71
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 746 pages. 9.25x6.25x1.25 inches. In Stock.